Long-Term Effects of Goshajinkigan in Prevention of Diabetic Complications: A Randomized Open-Labeled Clinical Trial
Figure 3
Progression of nephropathy. A total of 25 participants had nephropathy at the end of this study: 27.2% in goshajinkigan group and 18.7% in control group ().